Pathology is Human Work.
Expertise Matters.

Find out what this means for you, and your lab, at USCAP 2026

MEET WITH US

USCAP 2026 is just around the corner, and Proscia will be in San Antonio with a full slate of events, demos, and conversations about the future of digital pathology. We hope to see you there.

Visit Proscia in Booth #201

We're proud to arrive at USCAP having earned 2026 Best in KLAS in Europe, and the Top Score in the U.S.. Concentriq is now the highest-rated digital pathology platform, based entirely on customer feedback. 

DEMO CONCENTRIQ®
Pick a time that works for your USCAP schedule and get a firsthand experience of Concentriq, along with expert advice from our team. Bring your toughest questions and see what sets Concentriq apart. 

MEET WITH US
DSC07541 (1) copy

Can Technology Make Pathology More Human?

Lunchtime Symposium

March 24, 2026 | 12-1PM | Exhibitor Seminar Room 1

Pathology faces mounting pressure: rising administrative burden, operational strain, and declining reimbursement. Technology promises relief, but too often adds complexity instead of reducing it. Our speakers will share their perspectives on how technology can reduce friction in pathology workflows while keeping judgment, context, and clinical responsibility firmly in human hands. 

Derek Welch
Dr. Derek Welch
President and Chief Medical Officer, PathGroup
David McClintock
Dr. David McClintock
Chair of Computational Pathology, Mayo Clinic
David_West
David West
Chief Executive Officer, Proscia
Coleman Stavish
Coleman Stavish
Chief Technology Officer, Proscia

15 Minute In-Booth Partner Presentations

Daily at 10:00 AM and 2:30 PM | Booth #201
 
Proscia is hosting daily partner presentations and live product demos in our booth throughout the exhibition. Join us for brief, practical sessions focused on real-world applications and integrations with industry leaders.
2026-best-in-klas-digital-pathology-global-europe-800

Proscia Earns Best in KLAS in Europe
and the Top Score in the US

 Rated #1 by customers across multiple regions, Concentriq is recognized for proven diagnostic workflows and seamless interoperability. 100% of KLAS-surveyed customers would buy Concentriq again, and include it in their long-term plans. 
READ BEST IN KLAS 2026 FINDINGS

The Proscia and Concentriq Difference

Pathologist-workstation

Battle-tested at enterprise scale.

Thousands of diagnoses are made on Concentriq every single day, across the most complex lab environments.

Designed to retain and attract top pathologists.

An ergonomic, intuitive platform built for diagnostic focus.

Helping labs go from cost center to profit center.

Turn routine diagnostic data into actionable intelligence that creates millions in new, high-margin revenue.

AI-native architecture

Embed intelligence directly into workflows.

100+ LIS instances integrated and counting.

Leading interoperability isn’t a promise — it’s our track record.

Not Going to USCAP –
But Ready To Go Digital in 2026?

We created a practical buyer's guide for clinical labs evaluating digital pathology systems to help you define requirements before engaging vendors. It covers workflows, IT and integrations, regulatory, hardware, AI readiness, and much more. 

GET THE GUIDE
Proscia_Navy_Blue_logo_2

Proscia is rewiring pathology for precision medicine to improve patient outcomes. Its technology fuels the development and use of novel therapies and diagnostics, harnessing data and AI in the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies rely on these solutions each day, and Proscia was named Global 2026 Best in KLAS for Digital Pathology in Europe. For more information, visit proscia.com and follow Proscia on LinkedIn and X.

Concentriq Enterprise Pathology Platform
Solutions for Anatomic Pathology
Solutions for Life Sciences
About Proscia
Precision Medicine

© Copyright 2026. Proscia Inc., Proscia, Concentriq, Proscia Aperture, the circles logo and Proscia Aperture logo are trademarks or registered trademarks owned by Proscia Inc. All rights reserved.

Concentriq AP-Dx is FDA-cleared for primary diagnosis in the United States (U.S.) with the Hamamatsu NanoZoomer® S360MD Slide scanner and is licensed in Canada and CE‑marked under the EU IVDR for primary diagnosis. Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Concentriq AP and Concentriq LS are for Research Use Only. Not for use in diagnostic procedures.